SCHEMBL4264221

SCHEMBL4264221

CC(C)OC1=NS(=O)(=O)c2sc(Cl)cc2N1

nearest known ligand 0.45

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 12/20 0.45
KCNJ11 Q14654 12/20 0.45
GRIA1 P42261 2/20 0.30
GRIA2 P42262 2/20 0.30
GRIA3 P42263 2/20 0.30
GRIA4 P48058 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4260154 0.84 ABCC8 (0.46) ABCC8KCNJ11GRIA1GRIA2GRIA3
SCHEMBL8286612 0.76 ABCC8 (0.50) ABCC8KCNJ11GRIA1GRIA2GRIA3
SCHEMBL4255952 0.76 ABCC8 (0.43) ABCC8KCNJ11GRIA1GRIA2GRIA3
SCHEMBL6792625 0.76 ABCC8 (0.44) ABCC8KCNJ11GRIA1GRIA2GRIA3
SCHEMBL4261624 0.75 ABCC8 (0.45) ABCC8KCNJ11GRIA1GRIA2GRIA3
SCHEMBL27491407 0.75 ABCC8 (0.50) ABCC8KCNJ11GRIA1GRIA2GRIA3
SCHEMBL27491408 0.75 ABCC8 (0.50) ABCC8KCNJ11GRIA1GRIA2GRIA3
SCHEMBL2344068 0.75 ABCC8 (0.45) ABCC8KCNJ11GRIA1GRIA2GRIA3
SCHEMBL7078790 0.74 ABCC8 (0.44) ABCC8KCNJ11GRIA1GRIA2GRIA3
SCHEMBL6997132 0.73 ABCC8 (0.43) ABCC8KCNJ11GRIA1GRIA2GRIA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090012067-A1 Modulation of Hypothalamic Atp-Sensitive Potassium Channels ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. 2009-01-08 US disclosed
US-20090012067-A1 Modulation of Hypothalamic Atp-Sensitive Potassium Channels ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. 2009-01-08 US disclosed
US-20090012067-A1 Modulation of Hypothalamic Atp-Sensitive Potassium Channels ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. 2009-01-08 US disclosed
US-20070026079-A1 Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels DARA BIOSCIENCES, INC. 2007-02-01 US disclosed
US-20070026079-A1 Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels DARA BIOSCIENCES, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012067-A1 Modulation of Hypothalamic Atp-Sensitive Potassium Channels PYGB, PC, KCNN3 ABCC8 415/4885KCNJ11 18/4885GRIA1 1265/4885
US-20070026079-A1 Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels PC, LIPE, ATP5ME ABCC8 605/4885KCNJ11 24/4885GRIA1 1271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.